Microfluidic SPRi profiling of plasma extracellular vesicles enables eight-marker phenotyping for machine learning-assisted multi-cancer discrimination

Accurate discrimination of clinically related cancer types using circulating extracellular vesicles (EVs) remains challenging because plasma EVs are heterogeneous, low-abundance, and difficult to profile in a multiplexed and quantitative manner. Here, we developed a microfluidic surface plasmon resonance imaging (SPRi) platform for eight-marker EV protein phenotyping and machine learning-assisted multi-cancer discrimination. Heterogeneous EV populations were broadly captured through cholesterol–phospholipid membrane interactions, followed by protein-specific signal amplification using aptamer-functionalized gold nanoparticles targeting CD63, EGFR, EpCAM, HER2, ICAM-1, ITGB1, MUC1, and PD-L1. The platform achieved sensitive EV detection over 10³–10⁸ particles mL⁻¹, with a limit of detection below 10³ particles mL⁻¹, and showed favorable analytical reliability in specificity and spike-and-recovery assays. In 94 clinical plasma samples from healthy donors and patients with gastric cancer, colorectal cancer, or breast cancer, single-marker and averaged-response analyses revealed clear cancer-associated EV alterations but showed limited ability to resolve cancer type-specific differences. By integrating the eight-dimensional EV protein profiles, multiple machine learning models improved multi-cancer discrimination, with all six models achieving multiclass AUC values of 1.000 and five-fold cross-validation accuracies around 0.95 in the present cohort. This study demonstrates that microfluidic SPRi-based EV phenotyping can transform plasma EV surface protein signatures into model-recognizable discriminative patterns, providing a feasible liquid biopsy strategy for non-invasive multi-cancer discrimination.

Authors

Institutions

Publication Details

Journal
Journal of Nanobiotechnology
Published
2026-11-12
DOI
https://doi.org/10.1186/s12951-026-05254-9
Primary Topic
Extracellular vesicles in disease
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Microfluidic SPRi profiling of plasma extracellular vesicles enables eight-marker phenotyping for machine learning-assisted multi-cancer discrimination

Luyang Wang, Ziyang Zhou, 姜开阳 Jiang Kaiyang, Bo Yao et al.
Journal of Nanobiotechnology
Extracellular vesicles in disease
article

Microfluidic SPRi profiling of plasma extracellular vesicles enables eight-marker phenotyping for machine learning-assisted multi-cancer discrimination

Luyang Wang, Ziyang Zhou, 姜开阳 Jiang Kaiyang, Bo Yao, Jiayao Chen, Yushi Gao, Yuanyu Wang, Guangzhong Ma
article en

Abstract

Accurate discrimination of clinically related cancer types using circulating extracellular vesicles (EVs) remains challenging because plasma EVs are heterogeneous, low-abundance, and difficult to profile in a multiplexed and quantitative manner. Here, we developed a microfluidic surface plasmon resonance imaging (SPRi) platform for eight-marker EV protein phenotyping and machine learning-assisted multi-cancer discrimination. Heterogeneous EV populations were broadly captured through cholesterol–phospholipid membrane interactions, followed by protein-specific signal amplification using aptamer-functionalized gold nanoparticles targeting CD63, EGFR, EpCAM, HER2, ICAM-1, ITGB1, MUC1, and PD-L1. The platform achieved sensitive EV detection over 10³–10⁸ particles mL⁻¹, with a limit of detection below 10³ particles mL⁻¹, and showed favorable analytical reliability in specificity and spike-and-recovery assays. In 94 clinical plasma samples from healthy donors and patients with gastric cancer, colorectal cancer, or breast cancer, single-marker and averaged-response analyses revealed clear cancer-associated EV alterations but showed limited ability to resolve cancer type-specific differences. By integrating the eight-dimensional EV protein profiles, multiple machine learning models improved multi-cancer discrimination, with all six models achieving multiclass AUC values of 1.000 and five-fold cross-validation accuracies around 0.95 in the present cohort. This study demonstrates that microfluidic SPRi-based EV phenotyping can transform plasma EV surface protein signatures into model-recognizable discriminative patterns, providing a feasible liquid biopsy strategy for non-invasive multi-cancer discrimination.

Journal of Nanobiotechnology
University of Toronto (CA), Hangzhou Medical College (CN), Zhejiang University (CN)
National Natural Science Foundation of China
Good health and well-being
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon